"CD36 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.
| Descriptor ID |
D018955
|
| MeSH Number(s) |
D12.776.157.530.300.500 D12.776.395.550.625.136 D12.776.543.550.625.136 D12.776.543.585.300.500 D12.776.543.750.011 D12.776.543.750.705.675.136 D12.776.543.750.705.940.625.249 D12.776.543.750.710.450.750.625.249
|
| Concept/Terms |
CD36 Antigens- CD36 Antigens
- Antigens, CD36
- Thrombospondin Receptor
- Receptor, Thrombospondin
- Receptors, Thrombospondin
- Thrombospondin Receptors
- OKM5 Antigen
- Antigen, OKM5
- Platelet Glycoprotein IV
- Glycoprotein IV, Platelet
- Platelet Membrane Glycoprotein IIIb
- Platelet Glycoprotein IIIb
- Glycoprotein IIIb, Platelet
- SR-BI Protein
- SR BI Protein
- Adipocyte Membrane Protein p88
- CD36 Fatty Acid Transporter
- FAT (Fatty Acid Translocase) - CD36 Antigen
- CD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor)
- GPIV Platelet Glycoprotein
- Platelet Glycoprotein, GPIV
- GPIIIb Platelet Glycoprotein
- Platelet Glycoprotein, GPIIIb
- Scavenger Receptors, Class B, Type I
- SR-BI Receptor
- Receptor, SR-BI
- SR BI Receptor
- CD36 Protein
- CD36 Antigen
- Antigen, CD36
- Platelet Membrane Glycoprotein IV
|
Below are MeSH descriptors whose meaning is more general than "CD36 Antigens".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Carrier Proteins [D12.776.157]
- Membrane Transport Proteins [D12.776.157.530]
- Fatty Acid Transport Proteins [D12.776.157.530.300]
- CD36 Antigens [D12.776.157.530.300.500]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- Platelet Membrane Glycoproteins [D12.776.395.550.625]
- CD36 Antigens [D12.776.395.550.625.136]
- Membrane Proteins [D12.776.543]
- Membrane Glycoproteins [D12.776.543.550]
- Platelet Membrane Glycoproteins [D12.776.543.550.625]
- CD36 Antigens [D12.776.543.550.625.136]
- Membrane Transport Proteins [D12.776.543.585]
- Fatty Acid Transport Proteins [D12.776.543.585.300]
- CD36 Antigens [D12.776.543.585.300.500]
- Receptors, Cell Surface [D12.776.543.750]
- CD36 Antigens [D12.776.543.750.011]
- Receptors, Immunologic [D12.776.543.750.705]
- Platelet Membrane Glycoproteins [D12.776.543.750.705.675]
- CD36 Antigens [D12.776.543.750.705.675.136]
- Receptors, Scavenger [D12.776.543.750.705.940]
- Scavenger Receptors, Class B [D12.776.543.750.705.940.625]
- CD36 Antigens [D12.776.543.750.705.940.625.249]
- Receptors, Lipoprotein [D12.776.543.750.710]
- Receptors, LDL [D12.776.543.750.710.450]
- Receptors, Scavenger [D12.776.543.750.710.450.750]
- Scavenger Receptors, Class B [D12.776.543.750.710.450.750.625]
- CD36 Antigens [D12.776.543.750.710.450.750.625.249]
Below are MeSH descriptors whose meaning is more specific than "CD36 Antigens".
This graph shows the total number of publications written about "CD36 Antigens" by people in this website by year, and whether "CD36 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 3 | 1 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD36 Antigens" by people in Profiles.
-
Development of an Acrylamide-Based Inhibitor of Protein S-Acylation. ACS Chem Biol. 2021 08 20; 16(8):1546-1556.
-
IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol. 2021 03 05; 4(1):290.
-
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018 04; 37(17):2285-2301.
-
Proatherogenic Flow Increases Endothelial Stiffness via Enhanced CD36-Mediated Uptake of Oxidized Low-Density Lipoproteins. Arterioscler Thromb Vasc Biol. 2018 01; 38(1):64-75.
-
Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: Potential role of CD36. Sci Rep. 2017 02 27; 7:43648.
-
Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung Injury. J Immunol. 2016 07 15; 197(2):611-9.
-
Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell. 2009 Oct 16; 139(2):380-92.
-
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009 Sep 08; 106(36):15430-5.
-
Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring). 2009 Dec; 17(12):2142-8.
-
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet. 2009 Jul 15; 18(14):2683-92.